Clinical Trial

Intranasal Nafarelin For Triggering Oocyte Maturation

Study acronym: INFORM
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a non-inferiority randomised, controlled clinical trial comparing subcutaneous triptorelin to intranasal nafarelin for the final maturation of oocytes in women undergoing fertility preservation cycles with oocyte cryopreservation undergoing ovarian stimulation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-02; most recent amendment 2026-06-02.
Trial Details
NCT Number NCT06763926
Lead Sponsor Fundacion Dexeus
Conditions Fertility Preservation
Enrollment 154 participants
Start Date 2026-06-15
Primary Completion 2028-01-15 (estimated)
Study Completion 2028-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-04